Certified Scrum Product Owner (CSPO) Product Manager/Lead Business Analyst with 16+ years of unique experience in IT industry in Life Sciences domain and Medical profession currently working as Senior Manager in Life Sciences vertical of Cognizant Technology SolutionsSignificant experience in the Clinical domain executing domain intensive projects/software solutions. Trained in Pharmacovigilance from Symogen India (approved by WHO - Uppsala Monitoring Center, International Society of Pharmacovigilance and The Royal College of Physicians, London)Rich experience as a lead Business Analyst in implementation of one of Cognizant Life Sciences key proprietary products (a shared solution for delivering content and services to Investigator Sites developed under the guidance of consortium of 20 pharmaceutical organisations) in a US based global pharmaceutical organizationDeep experience as a Product Manager for one of the key proprietary products from Cognizant Life Sciences for acquisition of clinical and operational data from EDC systems into repositories and generating reports and dashboards helping pharmaceutical organizations in Risk Based MonitoringLeader of CDISC CDR CoE which is a domain differentiated group in the Cognizant’s R&D CoE playing key role in Governance, as an SME and in pre-sales in Clinical domain. Managed team of 70+ members including appraisals, promotions etc.Responsible for end to end execution of multiple data transformation projects in CDISC SDTM Standards (or Customer specific standards) for multiple global pharmaceutical organizations like Merck, Novo Nordisk, Astra Zeneca, Sanofi, Bayer Pharmaceuticals, IPSEN, LFB PharmaceuticalsCreated multiple training materials for Cognizant Academy in CDISC CDASH, SDTM and ADaM Standards which helped in training of all the associates of the service area; AZ certified trainerConducted classroom trainings for CDM and Biostats team of a global pharmaceutical organization in France on the CDISC Standards which prepared them for an internal project on Standardisation of CRFs in CDASH and Therapeutic Area specific domains and also plan their strategy for SDTM and ADaM transformationsThought Leadership – Co-authored a white paper abstract which was published at The 4th CDISC Japan Interchange, 2008. Co-authored white paper abstract which was selected for presentation at the 8th International Society of Pharmacovigilance (ISoP) Conference held at Buenos Aeris